Elekta tops STOXX as Q1 order surpasses expectations
28/08/2024 08:39
** Shares of Elekta EKTAb.ST jumped 10% after the Swedish
radiation therapy equipment maker reported Q1 orders ahead of
J.P. Morgan's expectations
** Stock is the best performer on pan-European STOXX 600
.STOXX index
** "We are experiencing strong customer interest in our
industry leading offerings and long-term underlying demand for
world-leading cancer care solutions," Elekta said
** "Sales were a 3.8% beat and adjusted EBIT came in 17.7%
ahead - a SEK 43 million ($4.23 million) beat - although we note
R&D capitalisation is up SEK 40 million year-on-year," J.P.
Morgan wrote in a note
** Elekta is expecting net sales to rise by a mid-single
digit percentage for 2024/25 fiscal year
** This growth is anticipated to be accompanied by an
improved EBIT margin, driven by the recent launch of new
product, Elekta Evo, the company says
($1 = 10.1693 Swedish crowns)
(Reporting by Agnieszka Olenska)
((Agnieszka.Olenska@thomsonreuters.com;))